Abbreviated Name

Therapeutic Approaches for Pancreatic Cancer

Lead Investigator

Maitra, Anirban — The University of Texas M D Anderson Cancer Center

Coordinating Investigator

Maitra, Anirban — The University of Texas M D Anderson Cancer Center

Involved Investigators

• Hanash, Samir — The University of Texas MD Anderson Cancer Center
• Maitra, Anirban — The University of Texas M D Anderson Cancer Center

Abstract

No abstract availalbe.

Aims

See manuscript

Analytic Method

No analytic method available.

Outcome

See manuscript

Publications

• A blood-based metabolomic signature predictive of risk for pancreatic cancer.

Biomarkers

• No biomarkers available at this time for this protocol.

Data Collections

• Blood-based metabolomic signature predictive of risk for pancreatic cancer

 Team Project

Start Date

Aug 1 2016

Estimated Finish Date

Jul 31 2021

Finish Date

Sep 19 2023

Protocol ID

490

Protocol Type

Collaboration

Fields of Research

• UNKNOWN

Collaborative Group

G.I. and Other Associated Cancers Research Group

Cancer Types

• Malignant neoplasm of pancreas